Table 1. Baseline clinical characteristics of AF group and non-AFheart disease control group.
AF patient (931) | Control 1 (663) | P | |
---|---|---|---|
Sex(M/F) | 529/402 | 363/300 | 0.542 |
Age(years) | 64.63±10.83 | 64.96±7.90 | 0.912 |
LAD, cm | 42.93±4.97 | 40.34±6.87 | 0.000 |
LVEDD, cm | 50.25±4.31 | 48.38±4.73 | 0.000 |
LVEF % | 59.85±6.43 | 60.51±5.58 | 0.014 |
Hypertenion | 36.8% | 39.6% | 0.225 |
Diabetes | 7.70% | 8.30% | 0.656 |
LAD-left atrial dimension
LVEDD-left ventricular end diastolic dimension
LVEF-left ventricular ejection fraction
Control 1-non-AFheart disease group